These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2121878)

  • 1. [A case of familial hypercholesterolemia associated with nephrotic syndrome].
    Nakai T; Matsuda T; Takai H; Maeda H; Takahashi S; Oida K; Tamai T; Miyaho S; Morikawa K; Kurota M
    Nihon Naika Gakkai Zasshi; 1990 Aug; 79(8):1079-80. PubMed ID: 2121878
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis and treatment of familial hypercholesterolemia].
    Makino I
    Hokkaido Igaku Zasshi; 1992 Jul; 67(4):437-40. PubMed ID: 1427588
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined effects of probucol and cholestyramine in familial type II hyperlipoproteinaemia.
    Pasquali R; Biso P; Parenti M; Melchionda N
    Lancet; 1981 Jun; 1(8234):1368. PubMed ID: 6113336
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
    Illingworth DR; Bacon S
    Arteriosclerosis; 1989; 9(1 Suppl):I121-34. PubMed ID: 2492189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escape phenomenon occurs by lowering cholesterol with a hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitor in patients with familial hypercholesterolemia.
    Yamamoto A; Yokoyama S; Yamamura T
    Atherosclerosis; 1988 Jun; 71(2-3):257-60. PubMed ID: 3135813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hypercholesterolemia.
    Kane JP; Havel RJ
    Annu Rev Med; 1986; 37():427-35. PubMed ID: 3518611
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.
    Mabuchi H; Sakai T; Sakai Y; Yoshimura A; Watanabe A; Wakasugi T; Koizumi J; Takeda R
    N Engl J Med; 1983 Mar; 308(11):609-13. PubMed ID: 6828091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational therapy of familial hypercholesterolemia.
    Reynolds GA
    Circulation; 1989 May; 79(5):1146-8. PubMed ID: 2496938
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined drug therapy--cholestyramine and compactin--for familial hypercholesterolemia.
    Yamamoto A; Yamamura T; Yokoyama S; Sudo H; Matsuzawa Y
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):493-7. PubMed ID: 6500769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined drug therapy for familial hypercholesterolemia.
    Packard CJ; Stewart JM; Morgan HG; Lorimer AR; Shepherd J
    Artery; 1980; 7(4):281-9. PubMed ID: 7213018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pravastatin, cholestyramine and gemfibrozil in long-term therapy of primary hypercholesterolemia. An open randomized comparative study].
    Ditschuneit HH; Dreyer M; Dammann HG; Ditschuneit H
    Med Klin (Munich); 1991 Mar; 86(3):142-8. PubMed ID: 1903497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin plus pravastatin for the treatment of heterozygous familial hypercholesterolaemia--a pilot study.
    Athyros VG; Papageorgiou AA; Demitriadis DS; Kontopoulos AG
    Curr Med Res Opin; 2001; 17(4):267-72. PubMed ID: 11922400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia.
    Wiklund O; Angelin B; Olofsson SO; Eriksson M; Fager G; Berglund L; Bondjers G
    Lancet; 1990 Jun; 335(8702):1360-3. PubMed ID: 1971660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the effectiveness of the HMG-CoA-reductase inhibitors pravastatin versus colestyramine in hypercholesteremia].
    Schwartzkopff W; Bimmermann A; Schleicher J
    Arzneimittelforschung; 1990 Dec; 40(12):1322-7. PubMed ID: 2128866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New combined therapy of niceritrol and probucol on heterozygous familial hypercholesterolemia.
    Yamamoto K; Fukushima N; Ozaki I; Setoguchi Y; Yanagita T; Sakai T
    Artery; 1991; 18(3):133-49. PubMed ID: 2069518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of low-dose cholestyramine in long-term therapy of hypercholesterolemia].
    Cattin L; Da Col PG; Fonda M; Mazzone C; Pertot P
    G Clin Med; 1990 Feb; 71(2):99-104. PubMed ID: 2347462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of LDL receptors and response to lovastatin therapy in familial homozygotic hypercholesterolemia].
    Ausina Gómez A; Gilsanz Peral A; Montero Brens C; Dalmau Serra J
    An Esp Pediatr; 1991 Nov; 35(5):327-31. PubMed ID: 1785747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of nutritional risks of special diets and drugs used in the management of familial hypercholesterolemia.
    Roe DA
    J Environ Pathol Toxicol Oncol; 1986; 6(3-4):151-9. PubMed ID: 3519931
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma lipoprotein changes after treatment with pravastatin and gemfibrozil in patients with familial hypercholesterolemia.
    Franceschini G; Sirtori M; Vaccarino V; Gianfranceschi G; Chiesa G; Sirtori CR
    J Lab Clin Med; 1989 Sep; 114(3):250-9. PubMed ID: 2504855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.